share_log

Merck & Co | 4: Statement of changes in beneficial ownership of securities-Director GLOCER THOMAS H

Merck & Co | 4: Statement of changes in beneficial ownership of securities-Director GLOCER THOMAS H

默沙東 | 4:持股變動聲明-董事 GLOCER THOMAS H
美股SEC公告 ·  07/02 13:25
Moomoo AI 已提取核心訊息
Thomas H. Glocer, a reporting person for Merck & Co., Inc. [MRK], has engaged in a transaction involving the company's common stock on 06/28/2024. Following the transaction, Glocer holds a total of 5,100 shares of Merck & Co. directly. The nature of the shares is direct ownership, indicating a personal investment in the company. The transaction details, including the number of shares transacted and the price per share, were not disclosed. This action reflects a change in Glocer's investment in the pharmaceutical giant, and it may be of interest to investors monitoring insider activity as an indicator of company performance and executive confidence.
Thomas H. Glocer, a reporting person for Merck & Co., Inc. [MRK], has engaged in a transaction involving the company's common stock on 06/28/2024. Following the transaction, Glocer holds a total of 5,100 shares of Merck & Co. directly. The nature of the shares is direct ownership, indicating a personal investment in the company. The transaction details, including the number of shares transacted and the price per share, were not disclosed. This action reflects a change in Glocer's investment in the pharmaceutical giant, and it may be of interest to investors monitoring insider activity as an indicator of company performance and executive confidence.
默沙東(Merck)公司的報告人 Thomas H. Glocer 於 2024 年 06 月 28 日參與了一項涉及該公司普通股的交易。交易後,Glocer 直接持有 5,100 股默沙東的股份。股份的性質爲直接所有權,表明對該公司進行了個人投資。交易的詳細信息,包括交易的股份數量和股票價格,未披露。此舉反映了 Glocer 在這家大型藥品公司中投資的變化,這可能對監測內部交易活動以及公司績效和管理層信心的投資者具有重要意義。
默沙東(Merck)公司的報告人 Thomas H. Glocer 於 2024 年 06 月 28 日參與了一項涉及該公司普通股的交易。交易後,Glocer 直接持有 5,100 股默沙東的股份。股份的性質爲直接所有權,表明對該公司進行了個人投資。交易的詳細信息,包括交易的股份數量和股票價格,未披露。此舉反映了 Glocer 在這家大型藥品公司中投資的變化,這可能對監測內部交易活動以及公司績效和管理層信心的投資者具有重要意義。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息